Lisata Therapeutics Inc (LSTA)

[F1ash]

BASKING RIDGE, N.J., August 2, 2016 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT) with a select therapeutic development pipeline, announces today that the Company will release financial results for the second quarter of 2016 after the U.S. financial markets close on Tuesday, August 9, 2016.

Caladrius’ management will host a conference call for the investment community beginning at 5:00 pm ET on Tuesday, August 9, 2016, to discuss the financial results, provide a company update and answer questions.

Shareholders and other interested parties may participate in the conference call by dialing 877-562-4460 (U.S.) or 513-438-4106 (international) and providing conference ID 95709219. The call will also be broadcast live on the Internet via the Company’s website at www.caladrius.com/events. The webcast will be archived on the Company’s website for 90 days.